From August 1, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on August 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.5 USD | +3.01% | +0.58% | +5.04% |
Apr. 22 | Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates | RE |
Apr. 22 | Moderna to deliver 12.5 million Covid vaccines to Brazil | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.04% | 40B | |
-0.02% | 42.11B | |
+43.29% | 40.08B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B | |
-18.61% | 9.87B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Tranche Update on Moderna, Inc.'s Equity Buyback Plan announced on August 3, 2022.